WHO ICTRP trial
The effect of hesperidin administration on endothelial function and gut barrier…
NL-OMON38722 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON38722 |
|---|---|
| Public title | The effect of hesperidin administration on endothelial function and gut barrier function |
| Scientific title | The effect of hesperidin administration on endothelial function and gut barrier function - The effect of hesperidin on endothelial function |
| Primary sponsor | Universiteit Maastricht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Netherlands |
| Conditions | verstoringen in intestinale barrierfunctie metabolic syndrome obesity overweight;10047066;metabolic syndrome;obesity;overweight |
| Interventions | Participants will be randomly assigned to one of the intervention groups. One group will receive one daily dose of Cordiart* 500 mg while the other group receives an identical looking placebo capsule for a period of 6 weeks. The capsules… |
| Registration date | Dec 23, 2013 |
| Target size | 70 |
| Secondary IDs | NL43456.068.13;Volgt, registratie in clinicaltrials.gov |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: